Clinical Trial Update: Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers [Phase 2]

View source ↗

Summary

Phase 2 results update on autologous tumor-infiltrating lymphocyte (TIL) therapy for metastatic HPV-associated cancers, with results posted after trial completi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Cervical Cancer
• Oropharyngeal Cancer
• Penile Cancer
• Vaginal Cancer

Drugs mentioned

• Tumor-infiltrating lymphocytes (TIL) therapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cervical Cancer, Oropharyngeal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-03-23